Education
About Us
Working with TipRanks
Follow Us
Willow Biosciences Inc (TSE:WLLW)
TSX:WLLW
RESEARCH TOOLSreports
Total Valuation
Willow Biosciences Inc has a market cap or net worth of C$724.23K. The enterprise value is C$11.03M.
Market CapC$724.23K
Enterprise ValueC$11.03M
Share Statistics
Willow Biosciences Inc has 144,846,540 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding144,846,540
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Willow Biosciences Inc’s return on equity (ROE) is -3.79 and return on invested capital (ROIC) is -235.64%.
Return on Equity (ROE)-3.79
Return on Assets (ROA)-1.95
Return on Invested Capital (ROIC)-235.64%
Return on Capital Employed (ROCE)-2.71
Revenue Per Employee61.68K
Profits Per Employee-685.74K
Employee Count19
Asset Turnover0.18
Inventory Turnover8.29
Valuation Ratios
The current PE Ratio of Willow Biosciences Inc is -0.95. Willow Biosciences Inc’s PEG ratio is 0.06.
PE Ratio-0.95
PS Ratio1.51
PB Ratio3.62
Price to Fair Value3.62
Price to FCF-1.08
Price to Operating Cash Flow-1.14
PEG Ratio0.06
Income Statement
In the last 12 months, Willow Biosciences Inc had revenue of 1.17M and earned -13.03M in profits. Earnings per share was -0.10.
Revenue1.17M
Gross Profit-659.00K
Operating Income-13.18M
Pretax Income-13.03M
Net Income-13.03M
EBITDA-11.06M
Earnings Per Share (EPS)-0.10
Cash Flow
In the last 12 months, operating cash flow was -4.46M and capital expenditures -78.00K, giving a free cash flow of -4.53M billion.
Operating Cash Flow-4.46M
Free Cash Flow-4.53M
Free Cash Flow per Share-0.03
Dividends & Yields
Willow Biosciences Inc pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.37
52-Week Price Change-88.89%
50-Day Moving Average0.03
200-Day Moving Average0.07
Relative Strength Index (RSI)20.99
Average Volume (3m)519.81K
Important Dates
Willow Biosciences Inc upcoming earnings date is May 14, 2025, TBA Not Confirmed.
Last Earnings DateMar 25, 2025
Next Earnings DateMay 14, 2025
Ex-Dividend Date―
Financial Position
Willow Biosciences Inc as a current ratio of 2.30, with Debt / Equity ratio of 902.05%
Current Ratio2.30
Quick Ratio2.18
Debt to Market Cap0.05
Net Debt to EBITDA0.09
Interest Coverage Ratio-92.83
Taxes
In the past 12 months, Willow Biosciences Inc has paid -5.00K in taxes.
Income Tax-5.00K
Effective Tax Rate<0.01
Enterprise Valuation
Willow Biosciences Inc EV to EBITDA ratio is -1.03, with an EV/FCF ratio of -0.99.
EV to Sales9.76
EV to EBITDA-1.03
EV to Free Cash Flow-0.99
EV to Operating Cash Flow-1.05
Balance Sheet
Willow Biosciences Inc has C$859.00K in cash and marketable securities with C$0.00 in debt, giving a net cash position of C$900.00K billion.
Cash & Marketable SecuritiesC$859.00K
Total DebtC$0.00
Net CashC$900.00K
Net Cash Per Share<C$0.01
Tangible Book Value Per ShareC$0.03
Margins
Gross margin is 62.29%, with operating margin of -1124.74%, and net profit margin of -1111.69%.
Gross Margin62.29%
Operating Margin-1124.74%
Pretax Margin-1112.12%
Net Profit Margin-1111.69%
EBITDA Margin-943.77%
EBIT Margin-1100.00%
Analyst Forecast
The average price target for Willow Biosciences Inc is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast297.78%
EPS Growth Forecast55.14%